Metraipolis › archive › dc_a018f27fa03f

Immunomodulatory crosstalk between GPCR and hippo signaling in cancer: implications for tumor immunity and therapeutic targeting — Europe PMC PMID:42199411

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42199411
DOI
10.3389/fimmu.2026.1765361
License (as archived)
solo-consultazione
Archived
2026-11-02T12:09:26.318Z
SHA-256 of the archived text
f5e9e608940f37fb64d274b944d7f917c8b65573eadc8a9135f2bd0412361595
Stable URL of this page
https://metraipolis.com/documento/dc_a018f27fa03f

How to cite

Immunomodulatory crosstalk between GPCR and hippo signaling in cancer: implications for tumor immunity and therapeutic targeting — Europe PMC PMID:42199411 — Europe PMC (en), https://europepmc.org/article/MED/42199411 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a018f27fa03f (Metraipolis archive dc_a018f27fa03f, sha256 f5e9e608940f37fb64d274b944d7f917c8b65573eadc8a9135f2bd0412361595)
BibTeX
@misc{dca018f27fa03f,
  title = {Immunomodulatory crosstalk between GPCR and hippo signaling in cancer: implications for tumor immunity and therapeutic targeting — Europe PMC PMID:42199411},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42199411},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a018f27fa03f; sha256 f5e9e608940f37fb64d274b944d7f917c8b65573eadc8a9135f2bd0412361595},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42199411. Agents can read the archived copy with the MCP tool read_document.